View More View Less
  • 1 Semmelweis Egyetem, Általános Orvostudományi Kar II. Belgyógyászati Klinika Budapest Szentkirályi u. 46. 1088
Open access

A szerzők egy 63 éves férfi beteg esetét mutatják be, akinél tüdőfibrosist, az arc bőrének kékesszürke elszíneződését, valamint szemészeti eltéréseket észleltek. A tünetek, illetve panaszok amiodaron szedésével függtek össze. Az amiodaronkezelés során gyakran jelentkező pajzsmirigybetegség (thyreoiditis, hyperthyreosis vagy hypothyreosis) a betegnél nem igazolódott. Az esetismertetéssel a szerzők az amiodaronkezelés mellékhatásaira kívánják felhívni a figyelmet. Orv. Hetil., 2013, 154(51), 2043–2047.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • Basaria, S., Cooper, D. S.: Amiodarone and the thyroid. Am. J. Med., 2005, 118, 706–714.

    Cooper D. S. , 'Amiodarone and the thyroid ' (2005 ) 118 Am. J. Med. : 706 -714.

  • Rao, R. H., McCready, V. R., Spathis, G. S.: Iodine kinetic studies during amiodarone treatment. J. Clin. Endocrinol. Metab., 1986, 62, 563–568.

    Spathis G. S. , 'Iodine kinetic studies during amiodarone treatment ' (1986 ) 62 J. Clin. Endocrinol. Metab. : 563 -568.

    • Search Google Scholar
  • Bogazzi, F., Bartalena, L., Brogioni, S., et al.: Desethylamiodarone antagonizes the effect of thyroid hormone at the molecular level. Eur. J. Endocrinol., 2001, 145, 59–64.

    Brogioni S. , 'Desethylamiodarone antagonizes the effect of thyroid hormone at the molecular level ' (2001 ) 145 Eur. J. Endocrinol. : 59 -64.

    • Search Google Scholar
  • Vorperian, V. R., Havighurst, T. C., Miller, S., et al.: Adverse effects of low dose amiodarone: a meta-analysis. J. Am. Coll. Cardiol., 1997, 30, 791–798.

    Miller S. , 'Adverse effects of low dose amiodarone: a meta-analysis ' (1997 ) 30 J. Am. Coll. Cardiol. : 791 -798.

    • Search Google Scholar
  • Martino, E., Safran, M., Aghini-Lombardi, F., et al.: Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann. Intern. Med., 1984, 101, 28–34.

    Aghini-Lombardi F. , 'Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy ' (1984 ) 101 Ann. Intern. Med. : 28 -34.

    • Search Google Scholar
  • Batcher, E. L., Tang, X. C., Singh, B. N., et al.: Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation. Am. J. Med., 2007, 120, 880–885.

    Singh B. N. , 'Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation ' (2007 ) 120 Am. J. Med. : 880 -885.

    • Search Google Scholar
  • Douglas, S. R., David, S. C., Jean, E. M.: Amiodarone and thyroid dysfunction. www.uptodate.com

  • Bouvy, M. L., Heerdink, E. R., Hoes, A. W., et al.: Amiodarone-induced thyroid dysfunction associated with cumulative dose. Pharmacoepidemiol. Drug Saf., 2002, 11, 601–606.

    Hoes A. W. , 'Amiodarone-induced thyroid dysfunction associated with cumulative dose ' (2002 ) 11 Pharmacoepidemiol. Drug Saf. : 601 -606.

    • Search Google Scholar
  • Martino, E., Bartalena, L., Mariotti, S., et al.: Radioactive iodine thyroid uptake in patients with amiodarone-iodine-induced thyroid dysfunction. Acta Endocrinol. (Copenh.), 1988, 119, 167–173.

    Mariotti S. , 'Radioactive iodine thyroid uptake in patients with amiodarone-iodine-induced thyroid dysfunction ' (1988 ) 119 Acta Endocrinol. (Copenh.) : 167 -173.

    • Search Google Scholar
  • Daniels, G. H.: Amiodarone-induced thyrotoxicosis. J. Clin. Endocrinol. Metab., 2001, 86, 3–8.

    Daniels G. H. , 'Amiodarone-induced thyrotoxicosis ' (2001 ) 86 J. Clin. Endocrinol. Metab. : 3 -8.

    • Search Google Scholar
  • Bartalena, L., Grasso, L., Brogioni, S., et al.: Serum interleukin-6 in amiodarone-induced thyrotoxicosis. J. Clin. Endocrinol. Metab., 1994, 78, 423–427.

    Brogioni S. , 'Serum interleukin-6 in amiodarone-induced thyrotoxicosis ' (1994 ) 78 J. Clin. Endocrinol. Metab. : 423 -427.

    • Search Google Scholar
  • Eaton, S. E., Euinton, H. A., Newman, C. M., et al.: Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography. Clin. Endocrinol. (Oxf.), 2002, 56, 33–38.

    Newman C. M. , 'Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography ' (2002 ) 56 Clin. Endocrinol. (Oxf.) : 33 -38.

    • Search Google Scholar
  • Piga, M., Cocco, M. C., Serra, A., et al.: The usefulness of 99mTc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis. Eur. J. Endocrinol., 2008, 159, 423–429.

    Serra A. , 'The usefulness of 99mTc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis ' (2008 ) 159 Eur. J. Endocrinol. : 423 -429.

    • Search Google Scholar
  • Eskes, S. A., Endert, E., Fliers, E., et al.: Treatment of amiodarone-induced thyrotoxicosis type 2: a randomized clinical trial. J. Clin. Endocrinol. Metab., 2012, 97, 499–506.

    Fliers E. , 'Treatment of amiodarone-induced thyrotoxicosis type 2: a randomized clinical trial ' (2012 ) 97 J. Clin. Endocrinol. Metab. : 499 -506.

    • Search Google Scholar
  • Osman, F., Franklyn, J. A., Sheppard, M. C., et al.: Successful treatment of amiodarone-induced thyrotoxicosis. Circulation, 2002, 105, 1275–1277.

    Sheppard M. C. , 'Successful treatment of amiodarone-induced thyrotoxicosis ' (2002 ) 105 Circulation : 1275 -1277.

    • Search Google Scholar
  • Jessurun, G. A., Crijns, H. J. G.: Amiodarone pulmonary toxicity. BMJ, 1997, 314, 619–620.

    Crijns H. J. G. , 'Amiodarone pulmonary toxicity ' (1997 ) 314 BMJ : 619 -620.

  • Camus, P., Martin, W. J. 2nd, Rosenow, E. C. 3rd: Amiodarone pulmonary toxicity. Clin. Chest Med., 2004, 25, 65–75.

    Rosenow E. C. , 'Amiodarone pulmonary toxicity ' (2004 ) 25 Clin. Chest Med. : 65 -75.

  • Okayasu, K., Takeda, Y., Kojima, J., et al.: Amiodarone pulmonary toxicity: a patient with three recurrences of pulmonary toxicity and consideration of the probable risk for relapse. Intern. Med., 2006, 45, 1303–1307.

    Kojima J. , 'Amiodarone pulmonary toxicity: a patient with three recurrences of pulmonary toxicity and consideration of the probable risk for relapse ' (2006 ) 45 Intern. Med. : 1303 -1307.

    • Search Google Scholar
  • Reĭngardene, D. I., Zhilene, V. I.: Dermatological adverse reactions of amiodarone. Kardiologiia, 2005, 45, 27–30.

    Zhilene V. I. , 'Dermatological adverse reactions of amiodarone ' (2005 ) 45 Kardiologiia : 27 -30.

    • Search Google Scholar
  • Gonzalez-Arriagada, W. A., Silva, A. R., Vargas, P. A., et al.: Facial pigmentation associated with amiodarone. Gen. Dent., 2013, 61, e15–e17.

    Vargas P. A. , 'Facial pigmentation associated with amiodarone ' (2013 ) 61 Gen. Dent. : e15 -e17.

    • Search Google Scholar
  • Bahadir, S., Apaydin, R., Çobanoilu, U., et al.: Amiodarone pigmentation, eye and thyroid alterations. J. Eur. Acad. Dermatol. Venereol., 2000, 14, 194–195.

    Çobanoilu U. , 'Amiodarone pigmentation, eye and thyroid alterations ' (2000 ) 14 J. Eur. Acad. Dermatol. Venereol. : 194 -195.

    • Search Google Scholar
  • Ioannides, M. A., Moutiris, J. A., Zambartas, C.: A case of pseudocyanotic coloring of skin after prolonged use of amiodarone. Int. J. Cardiol., 2003, 90, 345–346.

    Zambartas C. , 'A case of pseudocyanotic coloring of skin after prolonged use of amiodarone ' (2003 ) 90 Int. J. Cardiol. : 345 -346.

    • Search Google Scholar
  • Ingram, D. V.: Ocular effects in long-term amiodarone therapy. Am. Heart J., 1983, 106, 902–905.

    Ingram D. V. , 'Ocular effects in long-term amiodarone therapy ' (1983 ) 106 Am. Heart J. : 902 -905.

    • Search Google Scholar
  • Mäntyjärvi, M., Tuppurainen, K., Ikäheimo, K.: Ocular side effects of amiodarone. Surv. Ophthalmol., 1998, 42, 360–366.

    Ikäheimo K. , 'Ocular side effects of amiodarone ' (1998 ) 42 Surv. Ophthalmol. : 360 -366.

  • Vassallo, P., Trohman, R. G.: Prescribing amiodarone: an evidence-based review of clinical indications. JAMA, 2007, 298, 1312–1322.

    Trohman R. G. , 'Prescribing amiodarone: an evidence-based review of clinical indications ' (2007 ) 298 JAMA : 1312 -1322.

    • Search Google Scholar

 

The author instructions are available in PDF.
Instructions for Authors in Hungarian HERE.

 

Mendeley citation style is available HERE.
  • Impact Factor (2019): 0.497
  • Scimago Journal Rank (2018): 0.176
  • SJR Hirsch-Index (2018): 20
  • SJR Quartile Score (2018): Q3 Medicine (miscellaneous)
  • Impact Factor (2018): 0.564
  • Scimago Journal Rank (2018): 0.193
  • SJR Hirsch-Index (2018): 18
  • SJR Quartile Score (2018): Q3 Medicine (miscellaneous)

Language: Hungarian

Founded in 1857
Publication: Weekly, one volume of 52 issues annually

Senior editors

Editor(s)-in-Chief: Papp Zoltán

Read the professional career of Papp Zoltán HERE.

 

Editorial Board

Click for the Editorial Board

Akadémiai Kiadó
Address: Prielle Kornélia u. 21-35. H-1117 Budapest, Hungary
Phone: (+36 1) 464 8235 ---- Fax: (+36 1) 464 8221
Email: orvosihetilap@akkrt.hu